Hillstream Biopharma Probability of Future Stock Price Finishing Under 0.39
| HILSDelisted Stock | USD 0.39 0.01 2.50% |
Hillstream |
Hillstream Biopharma Target Price Odds to finish below 0.39
The tendency of Hillstream Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to move below current price in 90 days |
| 0.39 | 90 days | 0.39 | about 36.14 |
Based on a normal probability distribution, the odds of Hillstream Biopharma to move below current price in 90 days from now is about 36.14 (This Hillstream Biopharma probability density function shows the probability of Hillstream Stock to fall within a particular range of prices over 90 days) .
Given the investment horizon of 90 days Hillstream Biopharma has a beta of -1.51. This usually indicates as returns on its benchmark rise, returns on holding Hillstream Biopharma are expected to decrease by similarly larger amounts. On the other hand, during market turmoils, Hillstream Biopharma is expected to outperform its benchmark. Additionally Hillstream Biopharma has a negative alpha, implying that the risk taken by holding this instrument is not justified. The company is significantly underperforming the Dow Jones Industrial. Hillstream Biopharma Price Density |
| Price |
Predictive Modules for Hillstream Biopharma
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Hillstream Biopharma. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Hillstream Biopharma Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. Hillstream Biopharma is not an exception. The market had few large corrections towards the Hillstream Biopharma's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Hillstream Biopharma, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Hillstream Biopharma within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | -0.39 | |
β | Beta against Dow Jones | -1.51 | |
σ | Overall volatility | 0.17 | |
Ir | Information ratio | -0.06 |
Hillstream Biopharma Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Hillstream Biopharma for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Hillstream Biopharma can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Hillstream Biopharma is not yet fully synchronised with the market data | |
| Hillstream Biopharma has some characteristics of a very speculative penny stock | |
| Hillstream Biopharma has a very high chance of going through financial distress in the upcoming years | |
| Net Loss for the year was (8.47 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| Hillstream Biopharma currently holds about 9.48 M in cash with (6.56 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.82, which can makes it an attractive takeover target, given it will continue generating positive cash flow. | |
| Roughly 39.0% of the company shares are held by company insiders |
Hillstream Biopharma Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Hillstream Stock often depends not only on the future outlook of the current and potential Hillstream Biopharma's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Hillstream Biopharma's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 11.2 M | |
| Cash And Short Term Investments | 6.5 M |
Hillstream Biopharma Technical Analysis
Hillstream Biopharma's future price can be derived by breaking down and analyzing its technical indicators over time. Hillstream Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Hillstream Biopharma. In general, you should focus on analyzing Hillstream Stock price patterns and their correlations with different microeconomic environments and drivers.
Hillstream Biopharma Predictive Forecast Models
Hillstream Biopharma's time-series forecasting models is one of many Hillstream Biopharma's stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary Hillstream Biopharma's historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.
Things to note about Hillstream Biopharma
Checking the ongoing alerts about Hillstream Biopharma for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for Hillstream Biopharma help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
| Hillstream Biopharma is not yet fully synchronised with the market data | |
| Hillstream Biopharma has some characteristics of a very speculative penny stock | |
| Hillstream Biopharma has a very high chance of going through financial distress in the upcoming years | |
| Net Loss for the year was (8.47 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| Hillstream Biopharma currently holds about 9.48 M in cash with (6.56 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.82, which can makes it an attractive takeover target, given it will continue generating positive cash flow. | |
| Roughly 39.0% of the company shares are held by company insiders |
Check out Risk vs Return Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis. You can also try the Investing Opportunities module to build portfolios using our predefined set of ideas and optimize them against your investing preferences.
Other Consideration for investing in Hillstream Stock
If you are still planning to invest in Hillstream Biopharma check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Hillstream Biopharma's history and understand the potential risks before investing.
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine |